Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation.

[1]  A. Kennedy,et al.  Regulation of CTLA‐4 recycling by LRBA and Rab11 , 2021, Immunology.

[2]  M. Kramer,et al.  The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5 , 2021, Nature Communications.

[3]  J. Casanova,et al.  Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification , 2020, Journal of Clinical Immunology.

[4]  C. Smulski,et al.  Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. , 2019, Journal of autoimmunity.

[5]  G. Vereb,et al.  Signaling Lymphocyte Activation Molecule Family 5 Enhances Autophagy and Fine-Tunes Cytokine Response in Monocyte-Derived Dendritic Cells via Stabilization of Interferon Regulatory Factor 8 , 2018, Front. Immunol..

[6]  J. Pers,et al.  Human regulatory B cells control the TFH cell response , 2017, The Journal of allergy and clinical immunology.

[7]  R. Geha,et al.  Exaggerated follicular helper T‐cell responses in patients with LRBA deficiency caused by failure of CTLA4‐mediated regulation , 2017, The Journal of allergy and clinical immunology.

[8]  Yan Li,et al.  B cell activating factor (BAFF) selects IL‐10−B cells over IL‐10+B cells during inflammatory responses , 2017, Molecular immunology.

[9]  Z. Nemeth,et al.  Crohn’s Disease and Ulcerative Colitis Show Unique Cytokine Profiles , 2017, Cureus.

[10]  T. Tedder,et al.  The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity , 2017, Arthritis & rheumatology.

[11]  R. Geha,et al.  Spectrum of Phenotypes Associated with Mutations in LRBA , 2015, Journal of Clinical Immunology.

[12]  J. Hughes,et al.  Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy , 2015, Science.

[13]  Xiaodong Zhao,et al.  Effects of Wiskott–Aldrich Syndrome Protein Deficiency on IL‐10‐Producing Regulatory B Cells in Humans and Mice , 2015, Scandinavian journal of immunology.

[14]  Bodo Grimbacher,et al.  Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. , 2012, American journal of human genetics.

[15]  E. S. St. Clair,et al.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.

[16]  M. Goldman,et al.  Interleukin-12 family members and the balance between rejection and tolerance , 2008, Current opinion in organ transplantation.

[17]  M. Neurath,et al.  Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.

[18]  S. Zheng,et al.  Mesenchymal stromal cells attenuate multiple sclerosis via IDO-dependent increasing the suppressive proportion of CD5+ IL-10+ B cells. , 2019, American journal of translational research.

[19]  Toshiro K. Ohsumi,et al.  Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. , 2015, The Journal of allergy and clinical immunology.